Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study
Background. Glucagon-like peptide 1 (GLP-1) bestows protective effects upon the cardiovascular system through direct cardiovascular interactions or by improvements to metabolic function. Both these effects are thought to be at least partly mediated by the GLP-1 receptor (GLP-1R). This case-controlle...
Saved in:
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2018/1054192 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832563046395936768 |
---|---|
author | Xiaowei Ma Ran Lu Nan Gu Xiaowei Wei Ge Bai Jianwei Zhang Ruifen Deng Nan Feng Jianping Li Xiaohui Guo |
author_facet | Xiaowei Ma Ran Lu Nan Gu Xiaowei Wei Ge Bai Jianwei Zhang Ruifen Deng Nan Feng Jianping Li Xiaohui Guo |
author_sort | Xiaowei Ma |
collection | DOAJ |
description | Background. Glucagon-like peptide 1 (GLP-1) bestows protective effects upon the cardiovascular system through direct cardiovascular interactions or by improvements to metabolic function. Both these effects are thought to be at least partly mediated by the GLP-1 receptor (GLP-1R). This case-controlled study investigated whether polymorphisms in the GLP-1R gene affect the risk of cardiovascular disease in type 2 diabetic patients in the Chinese Han population. Methods. Eleven haplotype-tagging single nucleotide polymorphisms (SNPs), distributed across 22 kb of the 39 kb GLP-1R gene, were selected and genotyped in diabetic patients from a Chinese Han population. Patients were classified based on the severity of coronary artery stenosis. Coronary artery stenosis was ≥50% in 394 patients (coronary artery disease- (CAD-) positive group), and coronary artery stenosis was <50% in 217 patients (control group). Allele and genotype frequencies were compared between the two groups at all 11 SNPs. Results. When considered in recessive inheritance mode, patients with the GG genotype at rs4714210 had a lower CAD risk than patients with other genotypes (OR = 0.442, 95% CI = 0.258–0.757, p=0.002), even when other known CAD risk factors were taken into account (ORa = 0.440, 95% CIa = 0.225–0.863, pa=0.017). In additive inheritance mode, GG genotype carriers at rs4714210 exhibited a lower risk of CAD than AA carriers (ORa = 0.475, CIa = 0.232–0.970, pa=0.041). Conclusion. In type 2 diabetic patients from a Han Chinese population, some variations in the GLP-1R gene were associated with a lower risk of developing CAD. |
format | Article |
id | doaj-art-aee620716ce74f218240d492b9c2c6ba |
institution | Kabale University |
issn | 2314-6745 2314-6753 |
language | English |
publishDate | 2018-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Diabetes Research |
spelling | doaj-art-aee620716ce74f218240d492b9c2c6ba2025-02-03T01:21:08ZengWileyJournal of Diabetes Research2314-67452314-67532018-01-01201810.1155/2018/10541921054192Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control StudyXiaowei Ma0Ran Lu1Nan Gu2Xiaowei Wei3Ge Bai4Jianwei Zhang5Ruifen Deng6Nan Feng7Jianping Li8Xiaohui Guo9Department of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaDepartment of Cardiovascular, Peking University First Hospital, Beijing, ChinaDepartment of Endocrinology, Peking University First Hospital, Beijing, ChinaBackground. Glucagon-like peptide 1 (GLP-1) bestows protective effects upon the cardiovascular system through direct cardiovascular interactions or by improvements to metabolic function. Both these effects are thought to be at least partly mediated by the GLP-1 receptor (GLP-1R). This case-controlled study investigated whether polymorphisms in the GLP-1R gene affect the risk of cardiovascular disease in type 2 diabetic patients in the Chinese Han population. Methods. Eleven haplotype-tagging single nucleotide polymorphisms (SNPs), distributed across 22 kb of the 39 kb GLP-1R gene, were selected and genotyped in diabetic patients from a Chinese Han population. Patients were classified based on the severity of coronary artery stenosis. Coronary artery stenosis was ≥50% in 394 patients (coronary artery disease- (CAD-) positive group), and coronary artery stenosis was <50% in 217 patients (control group). Allele and genotype frequencies were compared between the two groups at all 11 SNPs. Results. When considered in recessive inheritance mode, patients with the GG genotype at rs4714210 had a lower CAD risk than patients with other genotypes (OR = 0.442, 95% CI = 0.258–0.757, p=0.002), even when other known CAD risk factors were taken into account (ORa = 0.440, 95% CIa = 0.225–0.863, pa=0.017). In additive inheritance mode, GG genotype carriers at rs4714210 exhibited a lower risk of CAD than AA carriers (ORa = 0.475, CIa = 0.232–0.970, pa=0.041). Conclusion. In type 2 diabetic patients from a Han Chinese population, some variations in the GLP-1R gene were associated with a lower risk of developing CAD.http://dx.doi.org/10.1155/2018/1054192 |
spellingShingle | Xiaowei Ma Ran Lu Nan Gu Xiaowei Wei Ge Bai Jianwei Zhang Ruifen Deng Nan Feng Jianping Li Xiaohui Guo Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study Journal of Diabetes Research |
title | Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study |
title_full | Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study |
title_fullStr | Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study |
title_full_unstemmed | Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study |
title_short | Polymorphisms in the Glucagon-Like Peptide 1 Receptor (GLP-1R) Gene Are Associated with the Risk of Coronary Artery Disease in Chinese Han Patients with Type 2 Diabetes Mellitus: A Case-Control Study |
title_sort | polymorphisms in the glucagon like peptide 1 receptor glp 1r gene are associated with the risk of coronary artery disease in chinese han patients with type 2 diabetes mellitus a case control study |
url | http://dx.doi.org/10.1155/2018/1054192 |
work_keys_str_mv | AT xiaoweima polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy AT ranlu polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy AT nangu polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy AT xiaoweiwei polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy AT gebai polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy AT jianweizhang polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy AT ruifendeng polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy AT nanfeng polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy AT jianpingli polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy AT xiaohuiguo polymorphismsintheglucagonlikepeptide1receptorglp1rgeneareassociatedwiththeriskofcoronaryarterydiseaseinchinesehanpatientswithtype2diabetesmellitusacasecontrolstudy |